Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11) - Image 1

£105.00

Springer Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)

Name: Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)
Brand: Springer
Price: 105.0 GBP
Availability: InStock

General Medical Issues

This is the most expensive it has ever been. Walk away.

£105 today · previous high £105 · all-time low £99

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 584 days • 584 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 584 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £99 (507 days, 86.8%)

Price range: £99 - £105

Price levels: 2 different prices over 584 days

Description

This book offers comprehensive information on the new and rapidly evolving science of identifying and targeting senescent cells, and on the exciting prospect of new diagnostic and therapeutic opportunities for stopping, and even reversing, the progression of disease and the deterioration of the human body due to ageing. According to recent United Nations data, by 2050 one in six people worldwide will be older than age 65, with peaks rising to one in four people in Europe and North America. Remarkably, the number of persons aged 80 years or older is expected to triple, from 143 million in 2019 to 426 million in 2050. First documented in the 1960s, the concept of cellular senescence as an underlying cause of ageing has been established in the course of the last decade. Using genetically engineered mouse models, researchers have demonstrated that the selective elimination of senescent cells can block and even reverse a number of age-related dysfunctions and pathologies, promoting both better health and longer life in the elderly. These include cardiovascular diseases; neurological disorders; type 1 and type 2 diabetes; inflammatory diseases; fibrosis; geriatric syndromes; chronic diseases resulting in organ dysfunction; the integrity of the musculoskeletal system; and cancer. Some senolytic agents have already progressed into trials. These include UBX0101 for the treatment of osteoarthritis (now in phase II), a cocktail of dasatinib and quercetin for the management of idiopathic pulmonary fibrosis and chronic kidney disease, and ABT-263 in combination with senescence-inducing chemotherapies for the treatment of advanced solid tumours. In addition, the book discusses pathways to early phase clinical trials and translational approaches in medicine and ageing, highlighting new opportunities as well as current limitations, challenges and alternatives. Given its scope, it will benefit a broad audience of advanced educators, researchers, graduate students and practitioners.

Product Specifications

Brand: Springer
Format: Paperback
ASIN: 303044905X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 29 April 2021
Listed Since: 01 April 2021

Barcode

No barcode data available

Springer Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)

Cellular Aging: 14 (Modern Cell Biology)

Cellular Senescence in Disease

The Biology of Aging: Observations and Principles

Humana Aging and Age-Related Disorders - Research Book

Humana Aging Methods and Protocols: 38 - Molecular Medicine

Model Systems in Aging: 3 (Topics in Current Genetics, 3)

Aging, Cancer and Age-related Disease: Common Mechanisms?, Volume 1197: 51 (Annals of the New York Academy of Sciences)

Aging: Methods and Protocols: 2144 (Methods in Molecular Biology, 2144)

Cellular Ageing and Replicative Senescence: 4 (Healthy Ageing and Longevity, 4)

Human Aging: From Cellular Mechanisms to Therapeutic Strategies

Cell Senescence: Methods and Protocols: 965 (Methods in Molecular Biology, 965)

Aging and Age-Related Disorders: 3 (Oxidative Stress in Applied Basic Research and Clinical Practice)

Molecular, Cellular, and Metabolic Fundamentals of Human Aging

Advances in Geroscience

Topics in Biomedical Gerontology

Springer - Topics in Biomedical Gerontology Research Book

Biochemistry and Cell Biology of Ageing: Part III Biomedical Science: 102 (Subcellular Biochemistry, 102)

Biochemistry and Cell Biology of Ageing: Part I Biomedical Science: 90 (Subcellular Biochemistry, 90)

Senescence Back and Forth

Apoptosis and Inflammation (Progress in Inflammation Research)

Aging of Cells in and Outside the Body: 2 (Biology of Aging and its Modulation, 2)

Handbook of Anti-Aging Medicine

Aging: Oxidative Stress and Dietary Antioxidants